ARTICLES BY TYLER MENICHIELLO
-
![Modular wooden houses-GettyImages-1323921102]( "How Modular Facility Design Can Accelerate GMP Facility Construction")
How Modular Facility Design Can Accelerate GMP Facility Construction5/20/2025Autolus Therapeutics' COO talks about the accelerated construction of the company's cell therapy manufacturing facility, The Nucleus.
-
![social media support service-GettyImages-2203248454]( "A Facilities Expert Answers Audience Questions On Construction And Validation")
A Facilities Expert Answers Audience Questions On Construction And Validation5/5/2025Bioprocessing facility expert Herman Bozenhardt responds to some unanswered audience questions from a Pharmaceutical Online Live event on facility design and validation.
-
![Pharmaceutical Production-GettyImages-2198724417]( "Experts' Advice On Facility Design And Construction")
Experts' Advice On Facility Design And Construction4/24/2025This is a review of the Pharmaceutical Online Live event “Facility Design And Validation Considerations For Drug Manufacturers," which featured industry experts Erich Bozenhardt and Herman Bozenhardt, as well as process architect Fred Grossfeld.
-
![business way-GettyImages-2075742031]( "Areas For Advancement In Peptide Manufacturing")
Areas For Advancement In Peptide Manufacturing2/27/2025Experts from Eli Lilly, NervGen, and Piramal Pharma Solutions discuss the myriad of ways peptide manufacturing can be improved, drawing on years of industry experience and insight.
-
![Environmentall Friendly-GettyImages-1341843646]( "For Gilead, Sustainability Is More Than A PR Effort")
For Gilead, Sustainability Is More Than A PR Effort2/14/2025Gilead's chief sustainability officer and SVP of operations, Joydeep Ganguly, explains the company's cultural focus on sustainability and how it influences everything from R&D to manufacturing.
Tyler Menichiello
Tyler Menichiello is a contributing editor to Bioprocess Online, Cell & Gene, and Clinical Leader. He interviews executives and subject matter experts across the biopharma industry to write about their successful approaches in biologics development from pre-IND planning all the way through trial design, manufacturing, and commercialization. He aims to investigate the industry’s most prevalent challenges and emerging best practices to provide both interesting and actionable content for industry leaders. Prior to writing for Life Science Connect, Tyler spent two years as a clinical research associate at the University of Pittsburgh Medical Center’s (UPMC) Hillman Cancer Center, where he worked on clinical trials involving hematological malignancies. He studied biology and journalism at Indiana University of Pennsylvania (IUP). You can email Tyler at tyler.menichiello@lifescienceconnect.com, or visit his LinkedIn profile.